| Logo | Name | Σ | Employees |
|---|---|---|---|
 |  Venionaire DealMatrix Transactions Made Easy. DealMatrix is a valuation engine that enables startups and investors to quickly and precisely calculate the value of their companies based on various valuation methods, map it against peers, and generate professional reports based on the findings. Investments, Startups, Due Diligence, Business Angels, Venture Capital, Corporate Scouting, Valuation, Investor, Venture Investor, Founder, and Matching | 49 | 7 |
 | European Circular Bioeconomy Fund (ECBF) A prosperous economy realigned with nature ECBF is a growth-stage venture capital fund established in Luxembourg dedicated to growth-stage investments within the European Circular Bioeconomy. We bring Europe's circular technologies to market, identifying the most promising investment targets, and syndicating with private and public investors to join financial rounds. Our mission is to provide access to finance to innovative solutions that enable the transitioning from a linear economy to a more sustainable circular one, having the European Investment Bank as a cornerstone investor. Our targeted investment sectors include new technologies and business models in Agtech; blue economy; and bio-based chemicals, … Type: Incubators & VCs | 20 | 32 |
 | In Extenso Innovation Croissance Consulting in strategic management of innovation and organizational transformation In Extenso Innovation Croissance supports innovative organizations on the major challenges of tomorrow by providing companies and public actors with the strategic vision of a partner capable of proposing and implementing scientific, technical, strategic, financial and fiscal recommendations in the field of sustainable innovation. With nearly 100 consultants mastering the entrepreneurial and sectoral challenges of their clients, In Extenso Innovation Croissance benefits from a strong territorial network, thanks to 8 regional offices, ensuring both reactivity and perfect knowledge of ecosystems and networks of decision-makers. In order to guarantee the quality of … Type: NGO, Think-tanks, Ed, & Culture Activities: consulting | 53 | 115 |
 |  La Financière de l'Echiquier Notre métier depuis 1991 : Investisseurs en entreprises Created in 1991, La Financière de l’Echiquier (LFDE) is one of France’s leading boutique asset management companies, with over €12billion in assets under management and a team of more than 130 employees. LFDE relies on its conviction-based management know-how to offer its institutional, distributor and private clients the responsible products and solutions they need to enhance their investments. LFDE is a subsidiary of the Primonial group, independent leader in France in the design, management and advice of investment solutions, and is also present in Switzerland, Italy, Germany, Austria, Spain and the Benelux … | 34 | 217 |
 | Debiopharm we develop for patients Bridging the gap between disruptive discovery products and real-world patient reach, we identify high-potential compounds for in-licensing, we conduct clinical development and then select large pharmaceutical commercialization partners for out-licensing to maximize patient access across the globe. Through this specialized business model, Debiopharm can focus on the development of prescription drugs that target unmet medical needs in oncology and bacterial infections. Debiopharm completed the development and has licensed out 2 compounds: - Triptorelin, the active substance of Decapeptyl®/Trelstar®/Pamorelin®/Triptodur® 1, 3 and 6-month formulation and Moapar®/Salcacyl® -Oxaliplatin, the active substance of the branded Eloxatin®/Elplat®/Dacotin®/Dacplat® If your university … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 15 | 488 |
 | IMBC SME financial partner IMBC (Invest Mons-Borinage-Center) is an actor of private law active in high balance sheet funding (venture capital) and support for SMEs, start-ups, spin-out and spin-off. Imbc offers financing solutions adapted to the needs of companies at any stage of life: from creation to transmission. Active for more than 30 years, the group has intervened for the benefit of more than 1,225 companies including 350 still in the portfolio. Venture Capital, SME, Start-ups, Investments, Loan, Risk Investments, Equity, Investment Facilitation, Spin-Off, Entrepreneurship, Family Business, Growth, Innovation, Success Story, Enterprise, Funding, and Wallonia Type: Incubators & VCs | 16 | 19 |
 | Germitec UV-C High-Level Disinfection for endocavitary and external ultrasound probes Germitec’s mission is to improve the standard of care by reducing cross-contamination risk and offering healthcare professionals with an automated solution that is fast, simple, safe, and environmentally friendly. Our products uses patented Yuvee® UV-C technology to provide High-Level Disinfection (HLD) for endocavitary and external ultrasound probes. ultrasound, disinfection, highleveldisinfection, infectioncontrol, ultraviolet, UVC, HLD, transducers, HPV, hightech, medtech, greentech, cleantech, frenchtech, healthtech, innovation, patientsafety, and infectionprevention Type: SMB Activities: deeptech manufacturing Technologies: Synthetic Biology | 14 | 67 |
 | SFPIM Federal Holding and Investment Company (Federale Participatie- en Investeringsmaatschappij / Société Fédérale de Participations et d'Investissement) was created on 1 November 2006 as a result of the merger between the Federal Participation Company and the Federal Investment Company, two public holding companies that each have their own history. The federal government is the sole shareholder in the Federal Holding and Investment Company. The Federal Holding and Investment Company (FHIC) centrally manages the federal government's shareholdings, cooperates with the government on specific projects and pursues its own investment policy in the interests of the Belgian economy. The FHIC has three core … | 24 | 54 |
 | Volotea Connecting Volotea Cities Volotea, the airline of Europe's medium-sized cities, was founded in 2011 and is one of the fastest-growing independent airlines in Europe. It reaches over 110 airports and is currently based in 21 European regional capitals. This year it plans to operate nearly 450 routes, offer between 12.5M to 13M seats, and operate around 80,000 flights. The company is committed to sustainable aviation and has launched over 50 initiatives to reduce carbon emissions. Skytrax has consecutively recognized Volotea as the 'Best Low-Cost Airline in Europe' in 2023 and 2024 based on its global passenger satisfaction survey. Travel, Transportation, … Type: Large company Activities: spacetech | 11 | 1,593 |
 | Ulysse Communication Who better than former journalists to make your voice heard? Ulysses Communication, at the crossroads of press and communication. Specializing in press relations and financial communication, Ulysse Communication was created by former economic and financial journalists who have themselves surrounded by former journalists. The agency and the team are strongly marked by this DNA which results in an intimate knowledge of the media, an ability to develop tailor-made messages and a good understanding of the economic world and businesses. Press relations, financial communication, finance, listed company, Introduction on the stock market, financial operations, public relations, corporate communication, asset management, real … Type: Media | 65 | 16 |
 | Shorla Oncology At Shorla Oncology we develop and commercialize innovative oncology medicines for women’s and pediatric cancers. At Shorla Oncology we develop and commercialize innovative oncology drugs. We focus on indications where existing treatments are limited, in shortage or inadequate for the target population. Our products are the result of Shorla’s world class team encompassing thought leaders, clinicians, scientists and commercial strategists who have extensive experience in the area of drug development and commercialization of niche cancer treatments. Our growing portfolio will bring accessible, affordable and life-saving treatments to patients, delivering a major contribution to patient care and providing a significant clinical … Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 8 | 38 |
 | Chiesi Group Chiesi is an international, research-focused biopharmaceuticals group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. The company’s mission is to improve people’s quality of life and act responsibly towards both the community and the environment. By changing its legal status to a Benefit Corporation in Italy, the US, and France, Chiesi’s commitment to create shared value for society as a whole is legally binding and central to company-wide decision-making. As a certified B Corp since 2019, we’re part of a global community of businesses that meet high standards of social and environmental impact. … Type: Large company | 14 | 5,725 |
 | Sygnature Discovery Sygnature Discovery is a world-leading integrated drug discovery contract research organization based in the UK and Canada with headquarters in Nottingham (UK). Additional sites are located in Alderley Park, Macclesfield, and Glasgow (UK), as well as Montreal and Quebec City (Canada). Its team of over 1,000 employees, which includes 900 scientists, partners with global biotech, pharma and NFP organizations. Since 2011, Sygnature Discovery has delivered 50 novel pre-clinical and 30 clinical compounds, with its scientists named on over 170 patents. Therapeutic areas of expertise include oncology, inflammation and immunology, neuroscience, metabolic diseases, infectious diseases, fibrotic diseases, and more. Founded in … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 15 | 664 |
 | SISTA Bring out a generation of leaders by reducing inequalities in funding between women and men Sista is a collective of women entrepreneurs and investors who promotes more diversity in the digital economy by encouraging in particular more investments in companies led by women. In partnership with all stakeholders in the ecosystem, the collective co-constructed good practices in order to fight against unconscious biases and bring out a generation of more diverse leaders. Created in December 2018, the collective is led by Céline Lazorthes, Tatiana Jama, Valentine de Lasteyrie and her board is composed of Nathalie Balla (La Redoute & Amp; … Type: NGO, Think-tanks, Ed, & Culture Activities: fintech | 138 | 109 |
 |  Dynacure Dynacure is a clinical-stage company focused on developing novel therapies for rare diseases. Dynacure is a clinical-stage company focused on developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Dynacure is developing DYN101, an investigational antisense product candidate designed to reduce the expression of dynamin 2 protein for the treatment of Myotubular and Centronuclear Myopathies, in strategic collaboration with Ionis Pharmaceuticals. Dynacure is also building a complementary research portfolio targeting other orphan disorders, including its DYN201 program for the treatment of Hereditary Spastic Paraplegias. Dynacure is headquartered in … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 7 | 11 |
 | Speedinvest Game-changing support for early-stage tech founders from our focused investment teams and in-house operational experts. Speedinvest is one of Europe’s most active early-stage investors with more than €1 billion AuM and 30+ investors based in Berlin, London, Munich, Paris, and Vienna. Founder success is our top priority, so we don’t just send some money and "check-in" at board meetings. Our mission is to empower you with game-changing support through every stage of your journey. Our focused investment teams know your industry inside and out. Their proven experience, know-how, and deep networks are yours from day one. You also have full … Type: Incubators & VCs | 148 | 131 |
 | Olivier Millet Member of the Executive Board @Eurazeo, @Eurrazeopme, Member of Ca @Europlace, Ex Mer Executive Committee @medef, former president @franceinveteu #privateequity #PME #ETI #esg | 12 | 28 |
 | SHARPSTONE Innovation financing advice and investor in SEED Sharpstone has developed an original and innovative approach by combining a consulting offer, Sharpstone Advisory (innovation financing) and an investment offer, Sharpstone Capital (SEED VC for technological startups). Concretely, Sharpstone Advisory is a decompartmental, financial and operational consulting firm, which can be summed up in 3 keywords: #Technologies, #Finance, #business. But, it is also and above all, a team of passionate and enthusiastic entrepreneurs. Strategic and financial advice, advice in improvement in economic performance, restructuring consulting, and non-dilutive financing Type: Incubators & VCs | 26 | 42 |
 | secpho We accelerate innovation through Deep Tech We are SECPHO, a technological innovation cluster formed by companies, technology centers and research groups, experts in Deep Tech, who firmly believe in collaboration. SECPHO is focused on promoting technological innovation by applying the DEEP TEC to all types of sectors of our economy. The main objectives of the cluster are: • Generate business opportunities for companies. • Facilitate access to projects, both national and international, for technology centers and research groups. • Promote innovation in the field of Deep Tech. These benefits are transferred to the partners through different actions such as Networking … Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech | 25 | 13 |
 | EQT Life Sciences EQT Life Sciences (formerly LSP) is one of Europe’s largest and most experienced healthcare investors. EQT Life Sciences, formerly LSP, is one of Europe’s largest and most experienced healthcare investors, targeting innovative life sciences and health care companies. Investment Firm, Healthcare, Biotechnology, Fund Management, Life Sciences, Venture Capital, Private Equity, ESG, and Impact Investing Type: Incubators & VCs | 14 | 27 |
 | TVM Capital Life Science Leading international VC providing capital and expertise to support breakthrough therapies and medical products TVM is a leading international venture capital firm focused on investing in life science innovations. The company has a highly experienced transatlantic investment team and approximately $900 million under management. TVM’s portfolio focuses on therapeutics and medical technologies from North America and the EU that represent differentiated first-in-class or best-in-class assets with the potential to transform standard of care. TVM pursues a unique two-pronged strategy, financing innovative early-stage therapeutics through a single asset company approach (Project-Focused Company, PFC) that leverages the firm’s strategic relationship with global … Type: Incubators & VCs | 7 | 44 |
 | Bayern Kapital Committed to high-tech & deep-tech Committed to high-tech and deeptech. As a hub of technology and innovation within Germany, Bavaria is one of the premier locations for up-and-coming high-tech companies and venture capital professionals in Europe. Since 1995 Bayern Kapital have been supporting young, Bavarian technology companies competently and patiently with venture and growth capital and access to a wide-reaching network. From seed phase to exit or IPO and during growth, scale-up, expansion and internationalization – we support Bavarian innovators in turning their business idea into an internationally successful business. Are you an entrepreneur? With ticket sizes of up to … Type: Incubators & VCs | 24 | 48 |
 | Parc Científic de Barcelona Where Science becomes Business The Barcelona Science Park is one of the leading ecosystems in Europe in research, technology transfer and innovation with more than 100,000m2 built and around 3,453 professionals working in 120 entities mainly in the health sector: pharmaceuticals, biotechnology, medical technologies, food and cosmetics. | 37 | 109 |
 | European Pharmaceutical Manufacturer A leading publisher in the pharma/biopharma manufacturing industries. European Pharmaceutical Manufacturer is a leading publisher covering the pharma/biopharma manufacturing supply chain from formulation to distribution, keeping readers informed of the latest news, opinions, developments and breakthroughs in this innovative and technologically advanced sector. Our portfolio consists of a monthly printed & digital magazine, online news source, weekly newsletters and active social media channels, not to mention regular contributions to The MedTalk Podcast. pharmaceuticalmanufacturer.media | @EPM_Magazine | #MedTalk Pharma, Manufacturing, Publishing, Medtech, and B2B Type: Media | 54 | 10 |
 | Voxdale | design-driven engineering Specialized in design-driven engineering services that ensure manufacturability and product success. Introducing Voxdale: your product development partner for success and innovation. In today’s competitive market, your hardware challenges need bold, innovative, and high-performing solutions. That’s where we come in. At Voxdale, we’ve spent nearly two decades designing and developing products to meet the specific business and consumer needs of start-ups, scale-ups, and multinational companies. Our creative team of experts, designers, and engineers will put your ideas through state-of-the-art simulations and prototyping to accelerate their development. The end result? Products that wow. With Voxdale on your team, you’ll be supported at … Type: Startup Activities: industry 4.0 Technologies: 3D Printing | 9 | 38 |
 | COFIDES Compañía Española de Financiación del Desarrollo, COFIDES S.A., S.M.E. COFIDES es una sociedad mercantil estatal que gestiona fondos financieros del Estado, así como recursos propios y de terceras instituciones con distintos objetivos: la internacionalización de la economía española, la atracción de inversión extranjera a sectores estratégicos en España, la promoción de la economía de impacto en España y la contribución al desarrollo de los países en los que invierte. En su accionariado, además del Estado, que ostenta una posición mayoritaria, participan el Banco Santander, Banco Bilbao Vizcaya Argentaria (BBVA), Banco Sabadell y CAF-Banco de Desarrollo de América Latina. Más información: … Type: SMB Activities: fintech Technologies: Decarbonization | 21 | 131 |
 | Creathor Ventures Backing the creators of our future. Creathor Ventures invests in technology-oriented companies that drive the automation of industry and business, and the personalization and digitalization of healthcare. The regional focus is on Germany and Switzerland. From its locations in Bad Homburg and Zurich, the team currently supports over 30 tech and healthcare companies. Over the past 30 years, the management team has financed over 200 companies as lead or co-lead investors. More than 20 companies have been listed on international stock exchanges. Creathor Ventures currently manages a fund volume of over 230 million euros. Venture Capital | 13 | 7 |
 | Tacalyx GmbH Tacalyx develops the next generation of anti-Cancer therapeutics in indications with high medical need Type: Startup Activities: deeptech Technologies: Synthetic Biology | 3 | 13 |
 | SciRhom Targeting iRhom2 for better treatment of autoimmune diseases SciRhom GmbH, based in IZB Martinsried, Germany, is a biotech start-up company that translates science into the preclinical and early clinical development of novel biopharmaceuticals for the treatment of life-threatening diseases. Founded in late 2016, we develop first-in-class antibodies against iRhom2, a key modulator of several crucial pro-inflammatory signalling pathways, including TNF-alpha signalling. Following the preclinical and early clinical development of these monoclonal antibodies, we are aiming to provide superior treatment options to currently existing inhibitors of TNF-alpha signaling. SciRhom is poised to transform the lives of patients with autoimmune diseases. drug … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 17 |
 | Health Innovation Port ... where health startups and relevant stakeholder from the healthcare sector come together to shape the future. We are collaboration space, incubator, accelerator, community, knowledge platform We rely on cooperation instead of competition in the middle of Hamburg. Here, startups from the health sector and established players in the healthcare industry come together to shape the future of healthcare together. Our goal? Interwoven in a strong partner network, we want to create a place where innovative ideas and new business models can develop and grow in the digital health market. What do we offer? In addition to access to the … Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech | 7 | 3 |
 | Sambrinvest We are the leading venture capital in Charleroi Metropole Sambrinvest est un acteur privé de capital à risque actif dans la région de Charleroi Métropole. Il a pour objet l'accompagnement et le développement des PME et des startups. Par son expertise, il conseille les entrepreneurs, à chaque stade de développement de leurs projets, tout en respectant leur autonomie de gestion. Venture Capital, SME, Startups, Investments, Equity, Loan, Risk Investments, and Hainaut Type: Incubators & VCs | 27 | 37 |
 | Memo Therapeutics AG Memo Therapeutics AG (“MTx”) is a late-stage biotech company translating unique human immune responses into superior medicines through the development of best-in-class antibodies to treat viral infections and cancer. The Company’s lead program, Potravitug, is in Phase II development targeting BK viremia (BKV) in kidney transplant recipients, an infection which can result in decreased kidney functionality and longevity and reduced patient survival. Potravitug has the potential to become the best and first-in-class BKV disease-modifying therapy for kidney transplant patients. Alongside Potravitug, MTx is focused on discovering novel antibody-target pairs for oncology based on tumor infiltrating B-cells derived leveraging tertiary lymphoid … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 4 | 44 |
 | SpainCap Capital for a sustainable future Spaincap is the association that groups Venture Capital & Amp entities; Private Equity in Spain, as well as its investors, including insurers and pension funds. Spaincap members invest in the medium and long term in non -listed companies, from Start UPS to consolidated companies, providing not only stable financing through capital, but also innovation and management support. The Employers' mission is to connect all industry actors in Spain, representing their interests before the administration, media and public opinion, both nationally and internationally, through alliances and synergies in Europe and Latin America. Among its objectives is … Type: Incubators & VCs | 27 | 17 |
 | Highland Europe We invest in rapidly growing European internet, mobile and software companies that address large market opportunities and have over €10 million in annualized revenues. Our capital enables management teams to accelerate growth and build a lasting, valuable business. Growth Capital, Technology, and Europe Type: Incubators & VCs | 23 | 38 |
 | Innogest Capital Investors in companies that make the difference, partner of entrepreneurial visionaries We are investors in companies that make the difference. We trust in great entrepreneurs, we partner with hard-working visionaries. Innogest is a Venture Capital firm focused on seed and early stage ventures, with more than € 200 milion of capital under management. We have over 100 years of cumulative professional experience in the digital and the healthcare fields. Innogest invests in high potential companies through a direct share in their equity and pays special attention to market potential and size. Innogest leverages its extensive network of contacts, working alongside … Tags: H2020 Type: Incubators & VCs | 11 | 15 |
 | Wellington Partners Wellington Partners is one of the most successful pan-European venture capital firms. With funds totalling over € 800 million, we have invested throughout Europe in companies that have the potential to become real market leaders for more than 15 years. We are committed to providing outstanding entrepreneurs with the necessary resources to fund their strategies. We typically lead financing rounds ranging from € 0.5 million to € 20 million. Depending on the maturity of the company, our own commitment can go as high as € 15 million. Providing funding is only one part of our business. After funding, the entrepreneurs … Type: Incubators & VCs | 27 | 7 |
 | Fountain Healthcare Partners Fountain Healthcare Partners is a life science venture capital firm based in Dublin Ireland with an office in New York. Fountain currently manages over €300M and is actively investing its third fund raised in 2019. The team at Fountain originally worked within the corporate VC group at Elan Corporation and raised its first independent fund in 2008. Fountain invests in drugs, devices and diagnostics with a focus on companies developing innovative products that address unmet medical needs and deliver significant pharmacoeconomic benefits. Venture Capital, Life Sciences, Medical Devices, Drug Delivery, Pharmaceuticals, Diagnostics, Speciality Pharma, and Biotechnology Type: Incubators & VCs | 10 | 11 |
 | Paladin Capital Group Paladin is a global investor that supports and grows the world’s most innovative cyber companies. Paladin Capital Group is a leading global investor that supports and grows the world’s most innovative companies through venture investment, expansion, and growth capital. We are headquartered in Washington, DC, with offices in London, Luxembourg, New York City, and Silicon Valley. We seek out diverse investment opportunities across the US and worldwide. Paladin is a leader in investing in technologies, products, and services focused on dual use in both commercial and governmental markets with a strong value-add culture. Paladin Cyber Fund: Our most recent fund … Type: Incubators & VCs | 34 | 61 |
 | Unquote Unquote is dedicated to providing insightful news, analysis and research surrounding the European private equity industry. While many other information sources rely purely on press releases they receive, unquote.com fully researches all the deals, funds and exits taking place in the market - fully verifying the information directly with the private equity deal-doers, fund managers, institutional investors and advisory communities. We have been researching the markets for over 20 years and that’s how we've become the leading European private equity specialists. Follow us for intelligence and analysis based on verified information and hard facts, not rumour and speculation. Type: Media | 37 | 2 |
 | Gilde Healthcare Specialized healthcare investor in both Healthcare Venture & Growth as well as Healthcare Private Equity, managing €2.5B Gilde Healthcare is a specialized European healthcare investor managing two business lines: a lower mid-market buy-out fund and a venture & growth capital fund. Gilde Healthcare's lower mid-market buy-out fund invests in profitable European healthcare services companies with a focus on the Netherlands, Belgium and Germany. The portfolio consists of healthcare providers, suppliers of medical products and other service providers in the healthcare market. Gilde Healthcare's venture & growth capital fund invests in medtech, diagnostics, digital health and therapeutics. The portfolio companies are … Type: Incubators & VCs | 11 | 73 |
 | BNP Paribas Fortis Ready for your world 🌍 At BNP Paribas Fortis, we strive to be a trusted financial companion for all our customers. No matter how big or small their dreams and challenges, we are there to help. As the go-to source for all things banking, our customers can count on us for reliable guidance. We are ready to help them make the right choices to achieve their goals. At BNP Paribas Fortis, we are ready for your world. Financial Services and Banking Type: Large company | 37 | 13,594 |
 | Innovation Forum We drive innovative technology development by connecting innovators, industry, and investors. The Innovation Forum is an international grassroots network that supports scientific entrepreneurs aiming to build ambitious companies at the intersection of science, technology and health. Their IMAGINE IF! initiative is a leading pre-acceleration programme for early-stage science-based ventures providing start-ups with extensive opportunities to take their venture to the next level through structured interactions with key stakeholders, tailored expert mentoring and connections with other founders and companies. Global branches: - UK: Cambridge, Oxford, London, Manchester - US: New York City - Switzerland: Lausanne - Spain: Barcelona - Serbia: Belgrade … Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech biotech | 32 | 49 |
 | BaseLaunch Accelerating Therapeutic Ventures BaseLaunch is the Basel-based incubator and accelerator that helps scientists and entrepreneurs launch exceptional biotech companies. It serves as a growth platform for early-stage ventures developing cutting-edge therapeutics. BaseLaunch helps build companies from inception through to Series A funding, providing financing and supporting all aspects of company creation and growth. It is operationally run and financed by Basel Area Business & Innovation, the investment and innovation promotion agency helping companies, institutions and startups find business success in the Basel area. BaseLaunch partners with leading global pharma and biotech companies and a venture fund – AbbVie, Roche, Novo … Type: Incubators & VCs | 19 | 15 |
 | redalpine #empoweringGameChangers redalpine is the Swiss venture capital firm that empowers GameChangers. Founded in 2006, redalpine brings together financial investment, operational expertise, and a vast international network to help ambitious entrepreneurs transform their vision into a reality. With over €1bn in assets under management and a disciplined, sector-agnostic investment strategy, the firm has backed some of Europe’s most disruptive companies, including N26, Taxfix, Inkitt, 9fin, Carvolution, Zenjob, vivenu, and Umiami. redalpine has over 95 companies in its portfolio and invests Europe-wide from its offices in Zurich and Berlin. Venture Capital, Startup Financing, Internet, and Life Science Type: Incubators & VCs | 34 | 45 |
 | Catalonia.Health (CataloniaBio & HealthTech) We're the organisation that represent companies in the #biomedicine and #health sector in Catalonia CataloniaBio & HealthTech is the organisation that represents companies in the biomedicine and health sector in Catalonia. It strives to defend and promote the interests of the business fabric in the sector; boost the competitiveness and size of companies so they can generate new products and services to make people healthier; create value in the sector by promoting innovation, entrepreneurship and the network, and position Catalonia as one of the top health hubs in the world. Created in 2006 through the initiative of several entrepreneurs in … Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech | 34 | 19 |
 | Verve Ventures Investing in technology and science-driven startups. Adding value through our exclusive network of investors. Verve Ventures is a network and technology-driven venture capital firm headquartered in Switzerland. Founded in 2010, Verve Ventures has grown to more than 45 team members and has become one of the most active venture investors in Europe with over 140 technology and science-driven startups in its portfolio. A dozen investment professionals identify the most promising digital, tangible, and health & bio startups. Verve Ventures provides its pan-European network of selected private and institutional investors access to those top-tier investment opportunities. The company invests from EUR … Type: Incubators & VCs | 25 | 77 |
 | Galion.exe Tech entrepreneurship is wild. Surround yourself with the right people. Type: Incubators & VCs Activities: it services | 14 | 29 |
 | European Investment Fund (EIF) Mobilising finance for Europe's startups and scaleups. Part of the EIB Group. #ETCI #InvestEU #eif4smes #believeinsmall Part of the EIB Group, the mission of the European Investment Fund (EIF) is to improve access to finance for SMEs and small mid-caps in Europe. We do this by supporting emerging and established fund managers with equity investments and by designing debt financing instruments that share the risk taken by financial institutions when they lend to or invest in small businesses. We bring this support closer to entrepreneurs through our extensive network of partners and financial intermediaries in all EU Member States and … Type: Incubators & VCs | 102 | 729 |
 | Webcapitalriesgo.com Webcapitalriesgo.com is an initiative that aims to contribute to transparency in the activity of Private Equity, Expansion and Venture Capital, Business Angels) in Spain. The germ of the project is in the research carried out since 1984 by José Martí Pellón, professor at the Complutense University of Madrid. In order to respond to the greatest challenges of information and the growth of the sector, www.webcapitalriesgo.com was created in 2000 to optimize both the acquisition and the dissemination of content on this financial activity. We are in contact with more than 200 investors of various types and sizes who invest in … Type: Incubators & VCs | 32 | 2 |
 | Pureos Bioventures Pureos is a venture capital fund investing in private innovative drug development companies Pureos Bioventures is a venture capital fund, which invests exclusively in private innovative drug development companies, with a special emphasis on the next generation of biological drugs and drug formats. The fund’s portfolio companies are built on scientific excellence to develop therapies across a broad indication spectrum including oncology, immunology, ophthalmology, rare diseases, and neuroscience. Pureos has built a team with deep investment, operating and clinical expertise, that strives to impact patients’ lives by advancing innovative treatments for devastating diseases. Type: Incubators & VCs | 6 | 14 |
 | MIG Capital Together, we build companies that move the world forward. MIG Capital is one of the leading German early-stage VC investors. We turn vision into value by providing financing to young innovative companies in Life Science and Deep Tech across Europe. Since our beginnings in 2004, we have invested more than €650 million in ~50 companies. Today, our portfolio consists of 30 groundbreaking companies. Venture capital, Entrepreneurship, Deep tech, Life sciences, and Private equity Type: Incubators & VCs | 18 | 25 |
 | Forbion Impacting the future of medicine Forbion was born out of ABN AMRO Capital Life Sciences in 2000. Six years later, we transitioned to Forbion Capital Partners. Today, to emphasize our value-add beyond merely providing capital, we are simply known as Forbion. For more than two decades, our investment team has built an impressive track record of sourcing, building and guiding life-sciences companies resulting in many breakthrough therapies and valuable exits. Forbion currently manages over €2.3 bn across ten funds. As of October 2022, Forbion holds 43 active portfolio companies bringing its investments to 95 companies to date with 46 employees. … Type: Incubators & VCs | 11 | 73 |
 | Thuja Capital Healthcare Investors Thuja Capital is an early-stage venture capital firm located in Utrecht, The Netherlands. We invest in product focused companies that aim to have true impact for patients and doctors alike, as demonstrated in clinical studies to enable a health claim. Hence most of our ventures are active in the field of therapeutics, medical devices and digital health. Not only do we invest, we also take an active role in helping the company to become successful, by leveraging our extensive network and by bringing our own experience to the table. red biotechnology, life sciences, medical technology, diagnostics, medical devices, … Type: Incubators & VCs | 11 | 18 |
 | EVERSANA EVERSANA® is a leading independent provider of global services to the life sciences industry. The company’s integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. The company serves more than 650 organizations, including innovative start-ups and established pharmaceutical companies, to advance life sciences solutions for a healthier world. To learn more about EVERSANA, visit eversana.com. Regulatory, Management & Specialty Consulting, Research & Insights, Global Pricing Strategies, Patient, Payer & Provider Marketing Services, Field Medical, Market Access & Sales , Global … Type: Large company | 4 | 4,560 |
 | CSL CSL is a leading global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our businesses, CSL Behring, CSL Seqirus, and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 32,000 people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations … Type: Large company | 15 | 22,792 |
 | Talent4Boards Inc. Great Talent builds Great Boards Talent4BoardsTM is a global Board news and publishing portal that focuses on Board visibility for public companies as well as VC/PE-backed companies. Talent4BoardsTM helps the Board members to shine in the spotlight as we consider them as experts - seasoned, bright, passionate, dedicated, and accountable -, and we support them for that. Talent4BoardsTM network is global and includes both Corporate Directors of Fortune 500 & Global 500 companies as well as those of Unicorns and other Start-ups/Growth companies. With over 10,000 guest members of Boards of Directors in main Stock Markets around the world, our … Type: Media | 43 | 1 |
 | Earlybird Venture Capital Earlybird is a venture capital investor focused on European technology companies Earlybird Venture Capital focuses on European technology companies. Founded in 1997, Earlybird identifies and backs exceptional early-stage companies on a pan-European basis and supports them through their growth and development phases – providing financial resources, strategic support, and access to an international network & capital markets. Earlybird invests out of a family of independently-managed funds. Flagship funds with early-stage focus include Digital West (Western Europe), Digital East (Emerging Europe), and Health. Newer funds Earlybird-X (pre-seed in Western Europe & university spinoffs) and Growth Opportunities (a pan-Earlybird growth fund) offer … Type: Incubators & VCs | 92 | 144 |
 | Tiendanimal Tiendanimal was founded in Malaga in 2006 as an online company, with the aim of improving the shopping experience of people with pets in their family 🏠 and offering excellent quality products. We currently have more than 100 physical stores throughout Spain and Portugal. We offer our customers the best service to meet all their needs. Are you coming to visit us? 🐱🐶 We will be happy to assist you! We offer a wide variety of products from major brands, as well as having our own manufacturing and exclusive sales brands! We also have services for all types of animals. … | 7 | 571 |
 | Heal Capital One of Europe’s leading venture capital funds dedicated to HealthTech. We back mission-driven founders with capital and immediate access to the healthcare system. From Seed to Series A, we invest € 1-5m in HealthTech startups across Europe. Heal Capital is one of Europe’s leading dedicated investment funds for integrated HealthTech with a total investment volume of over EUR 200m, backed by private health insurers and further health industry leaders. Type: Incubators & VCs | 11 | 13 |
 | VIVES Partners Making science investable 🌱 Empowering Innovation and Driving Growth Across Europe 🌱 At VIVES Partners, we are dedicated to fostering innovation by investing in local, regional, and European start-ups with a strong academic foundation. As managers of the VIVES Funds, our mission is to support groundbreaking ideas at their earliest stages, focusing on seed and early-stage technologies in life sciences, agritech, and engineering. We aim to build world-class technology companies that not only push the boundaries of science and engineering but also drive sustainable growth and make a global impact. 🌍🚀 If you are working on cutting-edge research or pioneering … Type: Incubators & VCs | 4 | 7 |
 | Lnk.Bio | 321 | 21 |
 | EQT Group EQT is a purpose-driven global investment organization EQT is a purpose-driven global investment organization with close to three decades of consistent investment performance across multiple geographies, sectors, and strategies. Type: Incubators & VCs | 40 | 1,291 |
 | LSX LSX is a growing influential community of senior life science decision makers. We are a catalyst for dialogue, debate and deal making to help lead growth in healthcare investment and the building of billion pound healthcare businesses. We are determined to forge a fundamentally better way to promote and facilitate investment, financing, partnerships and deal making in healthcare. Our community helps catalyse early stage innovation through peer-to-peer education and knowledge sharing, networking, partnering and deal making to champion the most innovative and exciting ideas. We bring deals to life., LSX is the network for life science executive leaders. Take a … Type: Media | 57 | 5 |